KR100283991B1 - Method for preparing bis-triazole derivative - Google Patents
Method for preparing bis-triazole derivative Download PDFInfo
- Publication number
- KR100283991B1 KR100283991B1 KR1019980021932A KR19980021932A KR100283991B1 KR 100283991 B1 KR100283991 B1 KR 100283991B1 KR 1019980021932 A KR1019980021932 A KR 1019980021932A KR 19980021932 A KR19980021932 A KR 19980021932A KR 100283991 B1 KR100283991 B1 KR 100283991B1
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- triazole
- oxirane
- difluorophenyl
- derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Epoxy Compounds (AREA)
Abstract
본 발명은 2-아세톡시-2′,4′-디플루오로아세토페논을 트리메틸설폭소늄 요오다이드와 반응시켜 2-아세톡시메틸-2-(2,4-디플루오로페닐-1-일)옥시란을 제조하고, 염기하에서 그로부터 아세틸기를 제거하여 2-하이드록시메틸-2-(2,4-디플루오로페닐-1-일)옥시란을 제조하고, 그것을 알킬 또는 치환되거나 비치환된 아릴설포닐 클로라이드와 반응시켜 2-설포닐옥시메틸-2-(2,4-디플루오로페닐-1-일)옥시란유도체를 제조하고, 그것을 1,2,4-트리아졸 나트륨염과 1:2의 당량비로 반응시킴으로써 부반응 없이 고수율로 화학식 1의 비스-트리아졸 유도체를 제조하는 방법에 관한 것이다.The present invention is a reaction of 2-acetoxy-2 ', 4'-difluoroacetophenone with trimethylsulfonium iodide to give 2-acetoxymethyl-2- (2,4-difluorophenyl-1- 1) preparing an oxirane and removing the acetyl group therefrom under a base to produce 2-hydroxymethyl-2- (2,4-difluorophenyl-1-yl) oxirane, which is alkyl or substituted or unsubstituted Reacted with arylsulfonyl chloride to prepare 2-sulfonyloxymethyl-2- (2,4-difluorophenyl-1-yl) oxirane derivative, which was then reacted with 1,2,4-triazole sodium salt. It relates to a method for preparing a bis-triazole derivative of formula (1) in a high yield without side reactions by reacting in an equivalent ratio of 1: 2.
[화학식 1][Formula 1]
Description
[산업상 이용분야][Industrial use]
본 발명은 항진균 작용을 갖는 화학식 1의 비스-트리아졸 유도체의 신규한 제조방법에 관한 것으로서, 더욱 상세하게는 화학식 8의 2-설포닐옥시메틸-2-(2,4-디플루오로페닐-1-일)옥시란 유도체를 1,2,4-트리아졸의 나트륨염과 반응시킴으로써 화학식 1의 비스-트리아졸 유도체를 제조하는 방법에 관한 것이다.The present invention relates to a novel process for the preparation of bis-triazole derivatives of formula (1) having antifungal action, more particularly 2-sulfonyloxymethyl-2- (2,4-difluorophenyl-) of formula (8). It relates to a method for preparing a bis-triazole derivative of formula (I) by reacting a 1-yl) oxirane derivative with the sodium salt of 1,2,4-triazole.
[화학식 1][Formula 1]
[화학식 8][Formula 8]
상기 식에서 R은 알킬 또는 치환되거나 비치환된 아릴기를 나타낸다.Wherein R represents an alkyl or substituted or unsubstituted aryl group.
[종래기술][Private Technology]
상기 화학식 1의 비스-트리아졸 유도체는 항진균 작용을 갖는 화합물로서, 일반명 플루코나졸로서 잘 알려져 있다. 현재까지 그 제조방법으로서 여러 가지 방법이 공지되어 있는 바, 그 대표적인 예는 하기와 같다.Bis-triazole derivative of Formula 1 is a compound having an antifungal action, it is well known as the common name fluconazole. Various methods are known as the production method so far, and representative examples thereof are as follows.
첫째 대한민국 특허공고 제 85-1132 호는 하기 반응식 1에 나타낸 바와 같이, 옥시란(oxirane) 구조를 갖는 화학식 2의 1-(2-(2,4-디플루오로페닐)-2,3-에폭시프로필]-1H-1,2,4-트리아졸을 1,2,4-트리아졸과 반응시켜 화학식 1의 비스-트리아졸 유도체를 제조하는 방법을 개시하고 있다.First, Korean Patent Publication No. 85-1132 discloses 1- (2- (2,4-difluorophenyl) -2,3-epoxy of Formula 2 having an oxirane structure, as shown in Scheme 1 below. Propyl] -1H-1,2,4-triazole is reacted with 1,2,4-triazole to prepare a bis-triazole derivative of formula (1).
[반응식 1]Scheme 1
한편 상기 화학식 2의 화합물은 하기 반응식 2와 같이 제조할 수 있다.Meanwhile, the compound of Formula 2 may be prepared as in Scheme 2 below.
[반응식 2]Scheme 2
그러나 상기 방법은 화학식 2의 화합물과 1,2,4-트리아졸의 반응성이 극히 낮아 화학식 1의 비스-트리아졸 유도체의 수율이 45%에 불과할 뿐만 아니라(상기 대한민국 특허공고 제 85-1132 호의 실시예 2(D) 참조), 상기 반응식 2에 나타낸 바와 같이, 화학식 2의 화합물은 상업적으로 이용가능한 1,3-디플루오로벤젠으로부터 3 단계의 반응을 거쳐 제조되는데 제2 단계 및 제3 단계의 수율이 매우 낮아(각각 40%와 22%), 최종적으로 1,3-디플루오로벤젠으로부터 화학식 1의 화합물의 총수율은 9.7%에 불과하다는 문제점이 있다.However, the method is extremely low in reactivity between the compound of formula 2 and 1,2,4-triazole, so that the yield of bis-triazole derivatives of formula 1 is only 45% (see Korean Patent Publication No. 85-1132). Example 2 (D)), as shown in Scheme 2 above, the compound of Formula 2 is prepared from a commercially available 1,3-difluorobenzene through three stages of reaction, the second and third stages of The yield is very low (40% and 22%, respectively), and finally there is a problem that the total yield of the compound of formula 1 from 1,3-difluorobenzene is only 9.7%.
둘째 상기 대한민국 특허공고 제 85-1132 호는 또다른 제조방법으로서 하기 반응식 3에 나타낸 바와 같이, 하기 화학식 3의 화합물을 2당량의 1,2,4-트리아졸과 반응시켜 화학식 1의 비스-트리아졸 유도체를 제조하는 방법을 개시하고 있다(스페인 특허 제 549020 호 참조).Second Korean Patent Publication No. 85-1132 discloses a bis-tria compound represented by Chemical Formula 1 by reacting a compound of Formula 3 with two equivalents of 1,2,4-triazole as shown in Scheme 3 as another manufacturing method. A process for preparing sol derivatives is disclosed (see Spanish Patent No. 549020).
[반응식 3]Scheme 3
상기 반응식 3에 나타낸 바와 같이, 상기 제조방법은 반응식상으로는 반응식 1보다 간단해 보이지만, 각 단계의 중간체를 칼럼 크로마토그래피 등의 방법으로 분리·정제하여야 하므로 반응공정이 복잡해지며, 반응중 사용되는 그리냐(Grignard) 시약이나 리튬염은 -78℃의 무수 조건하에서 제조되고 극히 불안정한 화합물이므로 대량생산 체계에는 부적합하다는 문제점이 있다.As shown in Reaction Scheme 3, the preparation method looks simpler than Reaction Scheme 1, but the intermediate step of each step is to be separated and purified by column chromatography, etc., the reaction process is complicated, the Green is used during the reaction (Grignard) Reagents or lithium salts are prepared under anhydrous conditions at -78 ° C and are extremely unstable compounds, which is not suitable for mass production systems.
셋째 미합중국특허 제 5,508,423 호는 하기 반응식 4에 나타낸 바와 같이, 상기 반응식 3과 유사한 방법으로 트리할로 유도체에 2당량의 1,2,4-트리아졸을 반응시킴으로써 화학식 1의 비스-트리아졸 유도체를 제조하는 방법을 개시하고 있다.Third, US Pat. No. 5,508,423 discloses a bis-triazole derivative of Formula 1 by reacting two equivalents of 1,2,4-triazole with a trihalo derivative in a manner similar to Scheme 3 below. Disclosed is a method of manufacturing.
[반응식 4]Scheme 4
그러나 상기 방법 또한 출발물질인 트리할로 유도체를 제조하는 공정의 수율이 매우 낮고 공정이 복잡할 뿐 아니라, 트리할로 유도체로부터 화학식 1의 비스-트리아졸 유도체를 제조하는 수율 또한 23%로 매우 낮다는 문제점이 있다.However, the method also has a very low yield and a complicated process for preparing a trihalo derivative as a starting material, and also a very low yield of 23% for preparing a bis-triazole derivative of Formula 1 from a trihalo derivative. Has a problem.
또딴 상기한 방법들은 공통적으로 1,2,4-트리아졸 환 중의 하나가 4-위치에 인접한 메틸렌에 부착되는 이성체로 혼입될 수 있어 그 불필요한 이성체를 실리카겔 크로마토그래피나 재결정법을 통하여 제거하여야 한다는 문제점이 있다.In addition, the above-mentioned methods can commonly be incorporated into isomers in which one of the 1,2,4-triazole rings is attached to the methylene adjacent to the 4-position, so that unnecessary isomers should be removed by silica gel chromatography or recrystallization. There is this.
넷째 본 발명과 관련된 기술로서. 국제공개 제 WO 93/09114 호는 하기 반응식 5에 나타낸 바와 같이, 화학식 4의 광학 활성을 갖는 옥시란 화합물을 제조하는 방법을 개시하고 있다.Fourth, as a technology related to the present invention. International Publication No. WO 93/09114 discloses a process for preparing an oxirane compound having optical activity of the formula (4), as shown in Scheme 5 below.
[반응식 5]Scheme 5
그러나, 상기 방법에서 화학식 4의 화합물은 항진균 효과를 갖는 테트라하이드로퓨란 유도체 제조과정 중의 일 중간체로서 광학 활성을 가지므로, 광학 활성을 갖지 않는 라세믹 화합물을 요구하는 화학식 1의 비스-트리아졸 유도체의 제조방법에는 직접 적응할 수 없다는 문제점이 있다.However, in the above method, since the compound of Formula 4 has optical activity as an intermediate in the process of preparing tetrahydrofuran derivative having an antifungal effect, the compound of Formula 1 requires a racemic compound having no optical activity. There is a problem that the manufacturing method can not be directly adapted.
이에 본 발명자들은 화학식 1의 비스-트리아졸 유도체를 제조하는데 있어서 , 상기한 바와 같은 종래기술의 문제점을 해결하기 위하여 집중적인 연구를 수행한 결과, 부반응 없이 고수율로 대량의 비스-트리아졸 유도체를 제조할 수 있는 신규한 제조방법을 안출해 내어 본 발명을 완성하기에 이르렀다.Accordingly, the present inventors conducted intensive studies to solve the problems of the prior art as described above in preparing the bis-triazole derivatives of the formula (1). A novel production method that can be produced was devised to complete the present invention.
본 발명은 상기한 종래기술의 문제점을 해결하기 위한 것으로서, 화학식 8의 2-설포닐옥시메틸-2-(2,4-디플루오로페닐-1-일)옥시란 유도체를 1,2,4-트리아졸의 나트륨염과 반응시킴으로써 부반응 없이 고수율로 대량의 화학식 1의 비스-트리아졸 유도체를 제조할 수 있는 방법을 제공하기 위한 것이다.The present invention is to solve the above problems of the prior art, the 2-sulfonyloxymethyl-2- (2,4-difluorophenyl-1-yl) oxirane derivative of the formula (8) 1,2,4 It is to provide a method for producing a large amount of bis-triazole derivative of formula (1) in high yield without side reactions by reacting with the sodium salt of -triazole.
본 발명은 화학식 8의 2-설포닐옥시메틸-2-(2,4-디플루오로페닐-1-일)옥시란 유도체를 1,2,4-트리아졸 나트륨염과 1:2의 당량비로 반응시키는 단계를 포함하는 화학식 1의 비스-트리아졸 유도체의 제조방법을 제공한다.The present invention provides a 2-sulfonyloxymethyl-2- (2,4-difluorophenyl-1-yl) oxirane derivative of formula 8 in an equivalent ratio of 1,2,4-triazole sodium salt and 1: 2. It provides a method for preparing a bis-triazole derivative of formula (I) comprising the step of reacting.
[화학식 1][Formula 1]
[화학식 8][Formula 8]
상기 식에서 R은 상기에서 정의한 바와 동일하다.In which R is the same as defined above.
화학식 8의 2-설포닐옥시메틸-2-(2,4-디플루오로페닐-1-일)옥시란 유도체는 화학식 5의 2-아세톡시-2′,4′-디플루오로아세토페논을 트리메틸설폭소늄 요오다이드((CH3)3SOI)와 반응시켜 화학식 6의 2-아세톡시메틸-2-(2,4-디플루오로페닐-1-일)옥시란을 제조하고, 염기하에서 상기 화학식 6의 2-아세톡시메틸-2-(2,4-디플루오로페닐-1-일)옥시란으로부터 아세틸기를 제거하여 화학식 7의 2-하이드록시메틸-2-(2,4-디플루오로페닐-1-일)옥시란을 제조하고, 상기 화학식 7의 2-하이드록시메틸-2-(2,4-디플루오로페닐-1-일)옥시란을 알킬 또는 치환되거나 비치환된 아릴설포닐 클로라이드와 반응시키는 단계를 포함하는 방법에 의해 제조되는 것이 바람직하다.2-sulfonyloxymethyl-2- (2,4-difluorophenyl-1-yl) oxirane derivative of formula (8) is a derivative of 2-acetoxy-2 ', 4'-difluoroacetophenone of formula (5) Reaction with trimethylsulfonium iodide ((CH 3 ) 3 SOI) to prepare 2-acetoxymethyl-2- (2,4-difluorophenyl-1-yl) oxirane of formula 6, To remove the acetyl group from 2-acetoxymethyl-2- (2,4-difluorophenyl-1-yl) oxirane of formula (6) Prepare difluorophenyl-1-yl) oxirane, and alkyl or substituted or unsubstituted 2-hydroxymethyl-2- (2,4-difluorophenyl-1-yl) oxirane of the formula Preferably prepared by a process comprising the step of reacting with arylsulfonyl chloride.
[화학식 5][Formula 5]
[화학식 6][Formula 6]
[화학식 7][Formula 7]
또한 상기 1,2,4-트리아졸 나트륨염은 1,2,4-트리아졸을 나트륨 하이드라이드(NaH)와 1.2:2의 당량비로 반응시켜 제조되는 것이 바람직하다.In addition, the 1,2,4-triazole sodium salt is preferably prepared by reacting 1,2,4-triazole with sodium hydride (NaH) in an equivalent ratio of 1.2: 2.
이하 본 발명을 더욱 상세하게 설명하면 하기와 같다.Hereinafter, the present invention will be described in more detail.
본 발명에 따른 화학식 1의 비스-트리아졸 유도체의 제조방법을 반응식으로 나타내면 하기 반응식 6과 같다.Representative method for preparing a bis-triazole derivative of formula 1 according to the present invention is shown in Scheme 6 below.
[반응식 6]Scheme 6
상기 반응식 6에 있어서, 출발물질인 화학식 5의 2-아세톡시-2′,4′-디플루오로아세토페논은 공지의 방법으로 제조될 수 있는 바, 예를 들면 하기 반응식 7에 나타낸 바와 같이 1,3-디플루오로벤젠으로부터 아실화 반응 및 치환 반응을 거쳐 제조될 수 있다.In Scheme 6, 2-acetoxy-2 ′, 4′-difluoroacetophenone of Formula 5, which is a starting material, may be prepared by a known method, for example, as shown in Scheme 7 below. It may be prepared from an, 3-difluorobenzene via an acylation reaction and a substitution reaction.
[반응식 7]Scheme 7
화학식 6의 2-아세톡시메틸-2-(2,4-디플루오로페닐-1-일)옥시란은 상응하는 케톤 화합물인 화학식 5의 2-아세톡시-2′,4′-디플루오로아세토페논을 트리메틸설폭소늄 요오다이드와 나트륨 하이드라이드로부터 제조된 디메틸옥소설포늄 메틸라이드와 반응시킴으로써 제조된다(단계 1). 이 반응은 통상적으로 디메틸 설폭사이드 용매내에서 무수 조건하의 0∼50℃의 온도에서 수행된다. 디메틸옥소설포늄 메틸라이드는 화학식 5의 화합물에 대하여 화학양론적양 이상의 양으로 사용하는 것이 바람직하며, 특히 화학식 5의 화합물 1당량에 대해 1.5∼2.0당량으로 사용하는 것이 바람직하다. 그런 다음 화학식 6의 2-아세톡시메틸-2-(2,4-디플루오로페닐-1-일)옥시란을 염기하에서 보호기, 즉 아세틸기를 제거함으로써 화학식 7의 2-하이드록시메틸-2-(2,4-디플루오로페닐-1-일)옥시란을 제조하게 되는데, 이때 반응용매로는 메탄올, 에탄올, 이소프로판올 또는 n-부탄올 등과 같은 알콜 화합물로부터 선택된 1종과 물의 혼합용매를 사용할 수 있으며, 염기로는 중탄산나트륨, 중탄산칼륨, 탄산나트륨, 탄산칼륨, 수산화나트륨 및 수산화리튬으로 이루어진 군으로부터 선택된 1종 이상을 사용할 수 있다(단계 2). 그렇게 얻은 화학식 7의 2-하이드록시메틸-2-(2,4-디플루오로페닐-1-일)옥시란을 유기염기 조건하에서 촉매량의 디메틸아미노 피리딘을 첨가한 다음 알킬 또는 치환되거나 비치환된 아릴설포닐 클로라이드와 반응시켜 하이드록시기가 설포네이트로 보호된 화학식 8의 2-설포닐옥시메틸-2-(2,4-디플루오로페닐-1-일)옥시란 유도체를 제조할 수 있다(단계 3). 이때 상기 촉매량은 화학식 7의 화합물에 대하여 0.005∼0.01당량으로 사용할 수 있다. 또한 반응용매로는 디클로로메탄, 클로로포름, 1,2-클로로에탄 등과 같은 염화탄소 화합물로부터 선택된 1종 이상을 사용할 수 있고, 알킬 또는 치환되거나 비치환된 아릴설포닐 클로라이드로는 메탄설포닐 클로라이드, 트리플루오로메탄설포닐 클로라이드, p-톨루엔설포닐 클로라이드, 벤젠설포닐 클로라이드 등에서 선택된 1종을 사용할 수 있고, 바람직하게는, 메탄설포닐 클로라이드 또는 p-톨루엔설포닐 클로라이드를 사용할 수 있으며, 유기염기로는 피리딘 또는 트리에틸아민을 사용할 수 있다.2-acetoxymethyl-2- (2,4-difluorophenyl-1-yl) oxirane of formula 6 is the corresponding ketone compound 2-acetoxy-2 ', 4'-difluoro of formula 5 Acetophenone is prepared by reacting dimethyloxosulfonium methylide prepared from trimethylsulfonium iodide and sodium hydride (step 1). This reaction is usually carried out in a dimethyl sulfoxide solvent at a temperature of 0-50 ° C. under anhydrous conditions. Dimethyloxosulfonium methylide is preferably used in an amount more than stoichiometric amount with respect to the compound of the formula (5), and particularly preferably in an amount of 1.5 to 2.0 equivalents per 1 equivalent of the compound of the formula (5). Thereafter, 2-acetoxymethyl-2- (2,4-difluorophenyl-1-yl) oxirane of formula (6) was removed under a base to remove a protecting group, ie, an acetyl group, to form 2-hydroxymethyl-2- of formula (7). (2,4-difluorophenyl-1-yl) oxirane is prepared, and a reaction solvent of water and one selected from alcohol compounds such as methanol, ethanol, isopropanol or n-butanol may be used as the reaction solvent. The base may be one or more selected from the group consisting of sodium bicarbonate, potassium bicarbonate, sodium carbonate, potassium carbonate, sodium hydroxide and lithium hydroxide (step 2). The 2-hydroxymethyl-2- (2,4-difluorophenyl-1-yl) oxirane of Formula 7 thus obtained was added with a catalytic amount of dimethylamino pyridine under organic base conditions and then alkyl or substituted or unsubstituted. By reacting with arylsulfonyl chloride, a 2-sulfonyloxymethyl-2- (2,4-difluorophenyl-1-yl) oxirane derivative of formula 8 in which the hydroxy group is protected with sulfonate can be prepared ( Step 3). In this case, the catalyst amount may be used in an amount of 0.005 to 0.01 equivalents based on the compound of Formula 7. As the reaction solvent, one or more selected from carbon chloride compounds such as dichloromethane, chloroform and 1,2-chloroethane may be used, and as alkyl or substituted or unsubstituted arylsulfonyl chloride, methanesulfonyl chloride, tri One selected from fluoromethanesulfonyl chloride, p-toluenesulfonyl chloride, benzenesulfonyl chloride, and the like may be used. Preferably, methanesulfonyl chloride or p-toluenesulfonyl chloride may be used. Pyridine or triethylamine can be used.
이어서 상기 화학식 8의 2-설포닐옥시메틸-2-(2,4-디플루오로페닐-1-일)옥시란 유도체 1,2,4-트리아졸 나트륨염과 1:2의 당량비로 반응시키게 된다(단계 4). 특히, 이 단계에서 종래에는 염기조건하에서 1,2,4-트리아졸을 가하고 가온함으로써 비스-트리아졸 유도체를 제조하였다. 즉 탄산칼륨 또는 탄산나트륨의 염기조건하에서 아세톤, 아세토니트릴, 디옥산, C1∼C2알콜 또는 물과 같은 극성용매 또는 그들의 혼합용매내에 상온∼120℃, 특히 90∼100℃에서 6∼7시간 동안 반응시킴으로써 수행되었다. 그러나 상기한 바와 같이 이때 1,2,4-트리아졸의 4-위치가 치환된 이성체가 혼입되어 칼럼 크로마토그래피 및 재결정방법에 의해 분리·정제하여야 할 뿐 아니라 반응 수율도 저하하는 문제점이 있었다. 이와 비교하여 본 발명에서는 1,2,4-트리아졸을 나트륨 하이드라이드와 무수 조건하에서 반응시켜 수득한 1,2,4-트리아졸 나트륨염을 화학식 8의 화합물과 반응시켜 화학식 1의 비스-트리아졸 유도체를 제조함으로써, 4-위치가 치환되는 이성체의 생성을 억제할 수 있다. 이때 반응용매로는 디메틸아세트아미드, 디메틸포름아미드 등의 아미드 화합물로부터 선택된 1종을 사용할 수 있으며, 반응온도는 상온∼100℃, 바람직하게는 60∼70℃인 바, 된 발명은 이 단계에서 반응온도를 저하시킬 수 있고 2시간내에 반응을 완결시킬 수 있으며 반응수율이 향상되는 효과를 갖는다 1,2,4-트리아졸 나트륨염은 60% 나트륨 하이드라이드와 1,2,4-트리아졸을 1.2:2의 당량비로, 특히 각각 2.4당량과 4당량씩 반응시켜 제조하는 것이 바람직하며, 화학식 8의 화합물에 대해 2.4∼4당량 사용하는 것이 바람직하다.Subsequently, the 2-sulfonyloxymethyl-2- (2,4-difluorophenyl-1-yl) oxirane derivative 1,2,4-triazole sodium salt of Formula 8 is reacted at an equivalent ratio of 1: 2. (Step 4). Particularly, at this stage, bis-triazole derivatives were prepared by adding and warming 1,2,4-triazole under basic conditions. That is, in a polar solvent such as acetone, acetonitrile, dioxane, C 1 -C 2 alcohol or water or a mixed solvent thereof under basic conditions of potassium carbonate or sodium carbonate for 6 to 7 hours at room temperature to 120 ° C, especially 90 to 100 ° C. It was carried out by reaction. However, as described above, isomers in which the 4-position of 1,2,4-triazole is substituted are mixed and separated and purified by column chromatography and recrystallization, and the yield of the reaction is also reduced. In contrast, in the present invention, the 1,2,4-triazole sodium salt obtained by reacting 1,2,4-triazole with sodium hydride under anhydrous conditions is reacted with a compound of Formula 8 to form bis-tria of Formula 1. By preparing a sol derivative, the production of isomers in which the 4-position is substituted can be suppressed. In this case, one kind selected from amide compounds such as dimethylacetamide and dimethylformamide may be used as the reaction solvent, and the reaction temperature is from room temperature to 100 ° C, preferably 60 to 70 ° C. It can lower the temperature, complete the reaction within 2 hours, and improve the reaction yield. The 1,2,4-triazole sodium salt contains 1.2% of 60% sodium hydride and 1,2,4-triazole. In an equivalent ratio of 2: 2, it is particularly preferable to produce 2.4 equivalents and 4 equivalents, respectively, and to use 2.4 to 4 equivalents based on the compound of the formula (8).
[실시예]EXAMPLE
이하 본 발명을 하기 실시예에 의거 보다 구체적으로 설명하고자 하나, 이는 본 발명의 이해를 돕기 위한 것일 뿐, 본 발명의 범위를 제한하고자 하는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to the following examples, which are only intended to aid the understanding of the present invention and are not intended to limit the scope of the present invention.
[[실시예 1] 2-아세톡시메틸-2-(2,4-디플루오로페닐-1-일)옥시란의 제조][Example 1] Preparation of 2-acetoxymethyl-2- (2,4-difluorophenyl-1-yl) oxirane
무수 디메틸설폭사이드 용액 250㎖에 60% 나트륨 하이드라이드(오일 분산) 3.74g(93.4mM)와 트리메틸설폭소늄 요오다이드 20.6g(93.4mM)을 서서히 첨가한 후, 맑은 용액이 될 때까지 실온에서 30분간 교반하였다. 반응용액을 0℃로 냉각시킨다음 2-아세톡시-2′,4′-디플루오로아세토페논 10g(46.7mM)을 서서히 첨가한 후 실온에서 2시간 동안 교반하였다. 반응용액을 빙수 500㎖에 분산시킨 후 에틸아세테이트 200㎖씩으로 2회 추출하였다. 유기층을 포화 염화나트륨 수용액으로 세척한 후 무수 황산마그네슘으로 탈수시키고 감압증류하여 오일상의 상기 표제 화합물 8.97g을 수득하였다(수율=75%). 그1H NMR 분석결과는 하기와 같다.Slowly add 3.74 g (93.4 mM) of 60% sodium hydride (oil dispersion) and 20.6 g (93.4 mM) of trimethylsulfonium iodide to 250 ml of anhydrous dimethylsulfoxide solution, until room temperature is obtained. Stir for 30 minutes. After the reaction solution was cooled to 0 ° C., 10 g (46.7 mM) of 2-acetoxy-2 ′, 4′-difluoroacetophenone was slowly added, followed by stirring at room temperature for 2 hours. The reaction solution was dispersed in 500 ml of ice water and extracted twice with 200 ml of ethyl acetate. The organic layer was washed with saturated aqueous sodium chloride solution, then dehydrated with anhydrous magnesium sulfate and distilled under reduced pressure to yield 8.97 g of the title compound as an oil (yield = 75%). The 1 H NMR analysis results are as follows.
1H NMR(300MHz, CDCl3) δ (ppm): 7.5∼7.47(m, 1H), 7.0∼6.8(m, 2H), 4.68(d, 1H, J=12.2Hz), 4.18(d, 1H, J=12.2Hz), 3.17(d, 1H, J=5.08Hz), 2.88(d, 1H J=5.08Hz) 2.04(s, 3H). 1 H NMR (300 MHz, CDCl 3 ) δ (ppm): 7.5 to 7.47 (m, 1H), 7.0 to 6.8 (m, 2H), 4.68 (d, 1H, J = 12.2 Hz), 4.18 (d, 1H, J = 12.2 Hz), 3.17 (d, 1H, J = 5.08 Hz), 2.88 (d, 1H J = 5.08 Hz) 2.04 (s, 3H).
[[실시예 2] 2-하이드록시메틸-2-(2,4-디플루오로페닐-1-일)옥시란의 제조][Example 2] Preparation of 2-hydroxymethyl-2- (2,4-difluorophenyl-1-yl) oxirane
실시예 1로부터 제조한 2-아세톡시메틸-2-(2,4-디플루오로페닐-1-일)옥시란 8.97g(35mM)을 메탄올 50㎖에 용해시키고 물 100㎖을 첨가한 후 탄산칼륨 4.84g(35mM)을 가하고 상온에서 1시간 동안 교반시켰다. 반응용액을 셀라이트 패드에 여과시키고 n-헥산 50㎖로 세척한 다음 디클로로메탄 100㎖씩으로 2회 추출하였다. 유기층을 무수 황산마그네슘으로 탈수시키고 용매를 감압증류하여 오일상의 상기 표제 화합물 6.12g을 수득하였다(수율=94%). 그1H NMR 분석결과는 하기와 같다.8.97 g (35 mM) of 2-acetoxymethyl-2- (2,4-difluorophenyl-1-yl) oxirane prepared in Example 1 was dissolved in 50 ml of methanol, and 100 ml of water was added thereto, followed by carbonic acid. 4.84 g (35 mM) of potassium was added and stirred at room temperature for 1 hour. The reaction solution was filtered through a pad of celite, washed with 50 ml of n-hexane, and extracted twice with 100 ml of dichloromethane. The organic layer was dehydrated with anhydrous magnesium sulfate and the solvent was distilled under reduced pressure to yield 6.12 g of the title compound as an oil (yield = 94%). The 1 H NMR analysis results are as follows.
1H NMR(300MHz, CDCl3) δ (ppm): 7.43∼7.35(m, 1H), 6.92∼6.78(m, 2H), 4.05∼3.87(m, 2H), 3.30(d, 1H, J=5.1Hz), 2.84(d, 1H, J=5.1Hz), 1.91(m, 1H). 1 H NMR (300 MHz, CDCl 3 ) δ (ppm): 7.43 to 7.35 (m, 1H), 6.92 to 6.68 (m, 2H), 4.05 to 3.87 (m, 2H), 3.30 (d, 1H, J = 5.1 Hz), 2.84 (d, 1H, J = 5.1 Hz), 1.91 (m, 1H).
[[실시예 3] 2-p-톨루엔설포닐옥시메틸-2-(2,4-디플루오로페닐-1-일)옥시란의 제조][Example 3] Preparation of 2-p-toluenesulfonyloxymethyl-2- (2,4-difluorophenyl-1-yl) oxirane
실시예 2로부터 제조한 2-하이드록시메틸-2-(2,4-디플루오로페닐-1-일)옥시란 14g(75.3mM)을 디클로로메탄 200㎖에 용해시킨 후 트리에틸아민 31.5㎖(3당량)과 디메틸아미노피리딘 140mg을 가하고 0℃로 냉각하였다. p-톨루엔설포닐 클로라이드 21.5g(1.5당량)을 천천히 적가한 후 상온에서 2시간 동안 교반시켰다. 반응이 완결된 후 물 100㎖을 첨가하여 세척한 다음 염화나트륨 수용액 50㎖로 세척하였다. 유기층을 무수 황산마그네슘으로 탈수시키고 용매를 감압증류하여 오일상의 상기 표제 화합물 23.8g을 수득하였다(수율=93%). 그1H NMR 분석결과는 하기와 같다.14 g (75.3 mM) of 2-hydroxymethyl-2- (2,4-difluorophenyl-1-yl) oxirane prepared in Example 2 was dissolved in 200 ml of dichloromethane, followed by 31.5 ml of triethylamine ( 3 equivalents) and 140 mg of dimethylaminopyridine were added and cooled to 0 ° C. 21.5 g (1.5 equivalents) of p-toluenesulfonyl chloride was slowly added dropwise, followed by stirring at room temperature for 2 hours. After the reaction was completed, the mixture was washed with 100 ml of water and then with 50 ml of aqueous sodium chloride solution. The organic layer was dehydrated with anhydrous magnesium sulfate and the solvent was distilled under reduced pressure to give 23.8 g of the title compound as an oil (yield = 93%). The 1 H NMR analysis results are as follows.
1H NMR(300MHz, CDCl3)δ (ppm): 7.67(d, 2H), 7.34∼7.26(m, 3H), 6.86∼6.83(m, 1H), 7.75∼6.67(m, 1H), 4.54(d, 1H, J=11.3Hz), 4.12(d, 1H, J=11.3Hz), 3.09(d, 1H, J=4.9Hz), 2.82(d, 1H, J=4.9Hz), 2.45(s, 3H). 1 H NMR (300 MHz, CDCl 3) δ (ppm): 7.67 (d, 2H), 7.34-7.26 (m, 3H), 6.86-6.63 (m, 1H), 7.75-6.67 (m, 1H), 4.54 ( d, 1H, J = 11.3 Hz, 4.12 (d, 1H, J = 11.3 Hz), 3.09 (d, 1H, J = 4.9 Hz), 2.82 (d, 1H, J = 4.9 Hz), 2.45 (s, 3H).
[[실시예 4] 2-(2,4-디플루오로폐닐)-1,3-비스-(1H-1.2,4-트리아졸-1-일)-2-프로판올의 제조][Example 4] Preparation of 2- (2,4-difluorophenyl) -1,3-bis- (1H-1.2,4-triazol-1-yl) -2-propanol]
디메틸포름아미드 250㎖에 60% 나트륨 하이드라이드 6.7g(169.4mM)을 첨가한 후 1,2,4-트리아졸 19.5g(282.4mM)을 서서히 적가하였다. 반응용액이 맑은 용액이 될 때까지 상온에서 30분간 교반하였다. 반응용액에 실시예 3으로부터 제조한 2-p-톨루엔설포닐옥시메틸-2-(2,4-디플루오로페닐-1-일)옥시란 24g(70.6mM)을 디메틸포름아미드 50㎖에 용해시킨 용액을 상온에서 적가하였다. 반응용액을 60∼70℃로 승온하고 2시간 동안 교반한 다음, 상온으로 냉각시키고 물 500㎖에 분산하였다. 에틸아세테이트 250㎖씩으로 2회 추출하고 유기층을 포화 염화나트륨 수용액 100㎖로 세척하였다. 유기층을 무수 황산마그네슘으로 탈수시키고 용매를 감압증류하여 생성된 결정의 조생성물을 디에틸에테르에 분산시킨 후 여과하여 백색 결정의 목적 화합물 18g을 수득하였다(수율=83.4%). 수득한 화합물을 분석한 결과를 하기에 나타내었다.After adding 6.7 g (169.4 mM) of 60% sodium hydride to 250 ml of dimethylformamide, 19.5 g (282.4 mM) of 1,2,4-triazole was slowly added dropwise. The reaction solution was stirred for 30 minutes at room temperature until a clear solution. In a reaction solution, 24 g (70.6 mM) of 2-p-toluenesulfonyloxymethyl-2- (2,4-difluorophenyl-1-yl) oxirane prepared in Example 3 was dissolved in 50 ml of dimethylformamide. The solution was added dropwise at room temperature. The reaction solution was heated to 60-70 ° C., stirred for 2 hours, cooled to room temperature and dispersed in 500 ml of water. Extracted twice with 250 ml of ethyl acetate and the organic layer was washed with 100 ml of saturated aqueous sodium chloride solution. The organic layer was dehydrated with anhydrous magnesium sulfate, and the solvent was distilled under reduced pressure to disperse the crude product of the crystal in diethyl ether, followed by filtration to obtain 18 g of the target compound as a white crystal (yield = 83.4%). The result of analyzing the obtained compound is shown below.
융점: 137.5∼139℃Melting Point: 137.5 ~ 139 ℃
IR(KBr): 3100, 1620cm-1 IR (KBr): 3100, 1620 cm -1
Mass: m/z : 306.8(MH+)Mass: m / z: 306.8 (MH +)
1H NMR(300MHz, CDCl3) δ (ppm): 8.06(s,2H), 7.86(s,2H), 7.47~7.39(m, 1H), 6.84∼6.75(m, 2H), 5.50(s, 1H), 4.75(d,2H,J=14.3Hz), 4.46(d,2H,J=14.3Hz). 1 H NMR (300 MHz, CDCl 3 ) δ (ppm): 8.06 (s, 2H), 7.86 (s, 2H), 7.47 ~ 7.39 (m, 1H), 6.84 ~ 6.75 (m, 2H), 5.50 (s, 1H), 4.75 (d, 2H, J = 14.3 Hz), 4.46 (d, 2H, J = 14.3 Hz).
본 발명에 따른 화학식 1의 비스-트리아졸 유도체의 제조방법을 사용하면 부반응 없이 고수율로 대량의 비스-트리아졸 유도체를 제조할 수 있다.By using the method for preparing a bis-triazole derivative of Formula 1 according to the present invention, a large amount of bis-triazole derivative can be prepared in high yield without side reaction.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019980021932A KR100283991B1 (en) | 1998-06-12 | 1998-06-12 | Method for preparing bis-triazole derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019980021932A KR100283991B1 (en) | 1998-06-12 | 1998-06-12 | Method for preparing bis-triazole derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20000001592A KR20000001592A (en) | 2000-01-15 |
KR100283991B1 true KR100283991B1 (en) | 2001-03-02 |
Family
ID=19539188
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019980021932A Expired - Fee Related KR100283991B1 (en) | 1998-06-12 | 1998-06-12 | Method for preparing bis-triazole derivative |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100283991B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10998580B2 (en) | 2018-04-02 | 2021-05-04 | Samsung Sdi Co., Ltd. | Electrolyte for rechargeable lithium battery and rechargeable lithium battery |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117126044B (en) * | 2023-04-12 | 2024-01-26 | 延边大学 | A microwave-assisted synthesis method of methyl ketone compounds |
-
1998
- 1998-06-12 KR KR1019980021932A patent/KR100283991B1/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10998580B2 (en) | 2018-04-02 | 2021-05-04 | Samsung Sdi Co., Ltd. | Electrolyte for rechargeable lithium battery and rechargeable lithium battery |
Also Published As
Publication number | Publication date |
---|---|
KR20000001592A (en) | 2000-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1996030360A1 (en) | Process for producing 1,4-benzodioxane derivatives | |
KR100984653B1 (en) | Process for preparing epoxytriazole derivatives and intermediates thereof | |
US5144042A (en) | Process for preparing optically active 3-hydroxypyrrolidine derivatives | |
KR940005012B1 (en) | Novel azetidine, its manufacturing process and its use as an intermediate for the preparation of bactericidal compositions | |
US10538539B2 (en) | Method for preparing 3-((2S, 5S)-4-methylene-5-(3-oxopropyl)tetrahydrofurane-2-yl) propanol derivative, and intermediate therefor | |
KR100283991B1 (en) | Method for preparing bis-triazole derivative | |
US4408063A (en) | Preparation of epihalohydrin enantiomers | |
US6700001B2 (en) | Process for stereoselective synthesis of 2-hydroxymethyl chromans | |
KR101435741B1 (en) | Novel voriconazole intermediate and synthesis of voriconazole | |
US4588824A (en) | Preparation of epihalohydrin enantiomers | |
CN109776612A (en) | A kind of synthetic method of phosphachromene derivative | |
US4727156A (en) | 3-(Substituted phenyl)-3-(1H-imidazol-1-ylmethyl)-2-methyl-5-{[(substituted phenyl)thio]me}isoxazolidine derivatives | |
JP3066594B2 (en) | Aniline derivative and method for producing the same | |
JP4057088B2 (en) | Method for producing pyrrolidine derivative | |
KR102395842B1 (en) | Novel method for preparation of epoxytriazole derivatives | |
US20090281301A1 (en) | Manufacturing Process of 2' ,2' - Difluoronucleoside and Intermediate | |
JP3527255B2 (en) | 6-N-substituted aminopicolinic acid derivatives and their production | |
JP2903805B2 (en) | Preparation of optically active benzyl glycidyl ether | |
KR100408431B1 (en) | Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one or pharmaceutically acceptable salts thereof | |
KR100209298B1 (en) | New amine ring compounds | |
US6194584B1 (en) | Process for preparing triazole antimycotic compounds | |
JP3159518B2 (en) | Preparation of amino-substituted spiro compounds | |
JP2818890B2 (en) | Method for producing allylamine compound and method for producing intermediate for producing same | |
JP2739506B2 (en) | Novel hydroxypyrrolidine compounds, intermediates for their production and methods for their production | |
KR100200246B1 (en) | Method for preparing triazole derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19980612 |
|
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 19980612 Comment text: Request for Examination of Application |
|
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20000531 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20001130 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20001214 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20001215 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20030224 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20040115 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20050325 Start annual number: 6 End annual number: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20060313 Start annual number: 7 End annual number: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20070228 Start annual number: 8 End annual number: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20080307 Start annual number: 9 End annual number: 9 |
|
FPAY | Annual fee payment |
Payment date: 20090306 Year of fee payment: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20090306 Start annual number: 10 End annual number: 10 |
|
LAPS | Lapse due to unpaid annual fee | ||
PC1903 | Unpaid annual fee |